Literature DB >> 12790838

Repeated courses of antenatal corticosteroids: is it justified?

Tse N Leung1, Po M Lam, Pak C Ng, Tze K Lau.   

Abstract

The benefits of a single course of antenatal corticosteroids on neonatal outcomes are well established. There is, however, much controversy about how long this treatment should continue, and whether repeated courses should be administered if the women remain at risk for preterm delivery 7 days after the initial therapy. This review aims to discuss current evidence on the effectiveness and safety of repeated courses of antenatal corticosteroids.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12790838     DOI: 10.1034/j.1600-0412.2003.00204.x

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  3 in total

1.  Antenatal dexamethasone treatment leads to changes in gene expression in a murine late placenta.

Authors:  B Baisden; S Sonne; R M Joshi; V Ganapathy; P S Shekhawat
Journal:  Placenta       Date:  2007-06-07       Impact factor: 3.481

2.  Prospective evaluation of fetuses with autoimmune-associated congenital heart block followed in the PR Interval and Dexamethasone Evaluation (PRIDE) Study.

Authors:  Deborah M Friedman; Mimi Y Kim; Joshua A Copel; Carolina Llanos; Claudine Davis; Jill P Buyon
Journal:  Am J Cardiol       Date:  2009-03-04       Impact factor: 2.778

3.  Levels of bone collagen markers in preterm infants: relation to antenatal glucocorticoid treatment.

Authors:  Eftichia Korakaki; Dimitrios Gourgiotis; Agisilaos Aligizakis; Antonia Manoura; Eleftheria Hatzidaki; Emmanuel Giahnakis; Antonios Marmarinos; Maria Kalmanti; Christina Giannakopoulou
Journal:  J Bone Miner Metab       Date:  2007-04-20       Impact factor: 2.626

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.